Placental-fetal glucose exchange and fetal glucose metabolism.

William W. Hay

PubMed · 2006 · 206 citations · 26 references

Concepts

TL;DR

Fetal glucose metabolism is governed by the combined influence of fetal plasma glucose and insulin. Glucose‑stimulated insulin secretion rises during gestation but is suppressed by constant hyperglycemia and enhanced by pulsatile hyperglycemia; in IUGR fetuses insulin production is reduced due to impaired beta‑cell replication, chronic hyperglycemia down‑regulates glucose tolerance and GLUT1/4 expression while chronic hypoglycemia up‑regulates them, producing a mixed phenotype of heightened glucose utilization but diminished protein synthesis and growth that may predispose to later insulin resistance, obesity, and diabetes.

Abstract

Fetal glucose metabolism depends on additive effects of fetal plasma glucose and insulin. Glucose-stimulated insulin secretion increases over gestation, is down-regulated by constant hyperglycemia, but enhanced by pulsatile hyperglycemia. Insulin production is diminished in fetuses with intrauterine growth restriction (IUGR) by inhibition of pancreatic beta-cell replication, but not by mechanisms that regulate insulin production or secretion, while the opposite occurs with hypoglycemia alone, despite its common occurrence in IUGR. Chronic hyperglycemia down-regulates glucose tolerance and insulin sensitivity with decreased expression of skeletal muscle and hepatic Glut 1 and 4 glucose transporters, while chronic hypoglycemia up-regulates these transporters. The opposite occurs for signal transduction proteins that regulate amino acid synthesis into protein. These results demonstrate the mixed phenotype of the IUGR fetus with enhanced glucose utilization capacity, but diminished protein synthesis and growth. Such adaptations might underlie childhood and adult metabolic disorders of insulin resistance, obesity, and diabetes mellitus.

References

26